JP2024096899A5 - - Google Patents

Download PDF

Info

Publication number
JP2024096899A5
JP2024096899A5 JP2024065962A JP2024065962A JP2024096899A5 JP 2024096899 A5 JP2024096899 A5 JP 2024096899A5 JP 2024065962 A JP2024065962 A JP 2024065962A JP 2024065962 A JP2024065962 A JP 2024065962A JP 2024096899 A5 JP2024096899 A5 JP 2024096899A5
Authority
JP
Japan
Prior art keywords
cell
cells
nucleic acid
acid encoding
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024065962A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024096899A (ja
Filing date
Publication date
Priority claimed from PCT/JP2019/027697 external-priority patent/WO2020013315A1/ja
Application filed filed Critical
Publication of JP2024096899A publication Critical patent/JP2024096899A/ja
Publication of JP2024096899A5 publication Critical patent/JP2024096899A5/ja
Pending legal-status Critical Current

Links

JP2024065962A 2018-07-13 2024-04-16 γδＴ細胞の製造方法 Pending JP2024096899A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2018133727 2018-07-13
JP2018133727 2018-07-13
JP2019117891 2019-06-25
JP2019117891 2019-06-25
PCT/JP2019/027697 WO2020013315A1 (ja) 2018-07-13 2019-07-12 γδＴ細胞の製造方法
JP2020530276A JP7479635B2 (ja) 2018-07-13 2019-07-12 γδＴ細胞の製造方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020530276A Division JP7479635B2 (ja) 2018-07-13 2019-07-12 γδＴ細胞の製造方法

Publications (2)

Publication Number Publication Date
JP2024096899A JP2024096899A (ja) 2024-07-17
JP2024096899A5 true JP2024096899A5 (enExample) 2024-11-01

Family

ID=69143058

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020530276A Active JP7479635B2 (ja) 2018-07-13 2019-07-12 γδＴ細胞の製造方法
JP2024065962A Pending JP2024096899A (ja) 2018-07-13 2024-04-16 γδＴ細胞の製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020530276A Active JP7479635B2 (ja) 2018-07-13 2019-07-12 γδＴ細胞の製造方法

Country Status (14)

Country Link
US (2) US12391739B2 (enExample)
EP (1) EP3822342A4 (enExample)
JP (2) JP7479635B2 (enExample)
KR (1) KR20210030373A (enExample)
CN (1) CN112513256A (enExample)
AU (1) AU2019302207B2 (enExample)
BR (1) BR112021000437A2 (enExample)
CA (1) CA3106089A1 (enExample)
CO (1) CO2021001064A2 (enExample)
IL (1) IL280041A (enExample)
MX (1) MX2021000459A (enExample)
SG (1) SG11202100260QA (enExample)
TW (1) TW202020145A (enExample)
WO (1) WO2020013315A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11629340B2 (en) 2017-03-03 2023-04-18 Obsidian Therapeutics, Inc. DHFR tunable protein regulation
SG11202100260QA (en) * 2018-07-13 2021-02-25 Univ Kyoto METHOD FOR PRODUCING γδ T CELLS
CN109337870B (zh) * 2018-12-24 2020-07-03 广东暨德康民生物科技有限责任公司 人Vγ9Vδ2T细胞扩增方法与培养基
CN115087731A (zh) * 2019-12-06 2022-09-20 菲特治疗公司 用小化合物增强iPSC衍生的效应免疫细胞
EP4170020A4 (en) 2020-06-17 2025-01-22 Kyoto University IMMUNOCOMPETENT CELLS WITH CHIMERIC ANTIGEN RECEPTOR EXPRESSION
KR20230128324A (ko) * 2021-02-05 2023-09-04 고쿠리츠다이가쿠호진 고베다이가쿠 인공 다능성 줄기 세포 유래 γδ T 세포 및 그 제작방법
BR112023018844A2 (pt) * 2021-04-07 2023-10-10 Century Therapeutics Inc Composições e métodos para geração de células t gama-delta de células-tronco pluripotentes induzidas
CN113583955A (zh) * 2021-08-24 2021-11-02 羽铂精制生物技术(成都)有限公司 一种因子法扩增t细胞的培养基及培养方法
CN118871572A (zh) * 2021-10-14 2024-10-29 阿彼雅生物有限公司 使用多种t细胞受体对干细胞t细胞进行工程化
EP4430198A4 (en) * 2021-11-12 2025-12-03 Janssen Biotech Inc SUBSTANCES AND METHODS FOR IMPROVED MULTIPLICATION AND USES OF IMMUNE CELLS
WO2023149555A1 (ja) 2022-02-04 2023-08-10 国立大学法人京都大学 Ｔ細胞の製造方法
KR20240170816A (ko) 2022-04-04 2024-12-04 감마델타 테라퓨틱스 엘티디 신규의 유전자 아모링
WO2023194911A1 (en) * 2022-04-04 2023-10-12 Gammadelta Therapeutics Ltd Cells expressing an anti-mesothelin car
CN118931834B (zh) * 2024-03-07 2025-09-16 珠海善行免疫微生态产业研究院有限公司 一种人Vγ9Vδ2T细胞扩增培养基及其扩增培养方法
CN119530215A (zh) * 2024-11-27 2025-02-28 珠海医米诺赛医学检验有限公司 一种血液处理液及利用该处理液进行染色体核型分析的方法

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937190A (en) 1987-10-15 1990-06-26 Wisconsin Alumni Research Foundation Translation enhancer
NZ522337A (en) 2000-04-03 2004-12-24 Hemosol Inc Production of TcR gamma delta T cells
US9453219B2 (en) 2003-05-15 2016-09-27 Mello Biotech Taiwan Co., Ltd. Cosmetic designs and products using intronic RNA
JPWO2006006720A1 (ja) 2004-07-13 2008-05-01 株式会社メディネット γδＴ細胞の培養方法、γδＴ細胞及び治療・予防剤
EP4223769A3 (en) 2005-12-13 2023-11-01 Kyoto University Nuclear reprogramming factor
CN101743306A (zh) 2007-03-23 2010-06-16 威斯康星校友研究基金会 体细胞重编程
US9051391B2 (en) 2007-06-11 2015-06-09 Takara Bio Inc. Method for expression of specific gene
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
EP3078738B1 (en) 2007-08-31 2020-05-20 Whitehead Institute for Biomedical Research Wnt pathway stimulation in reprogramming somatic cells
AU2008297024B2 (en) 2007-10-31 2014-08-28 Kyoto University Nuclear reprogramming method
AU2008286249B2 (en) 2007-12-10 2013-10-10 Kyoto University Efficient method for nuclear reprogramming
CA2709566A1 (en) 2007-12-17 2009-06-25 Gliamed, Inc. Stem-like cells and method for reprogramming adult mammalian somatic cells
JP5945385B2 (ja) 2008-01-16 2016-07-05 リン、シー−ランLIN, Shi−Lung 誘導性組換えｒｎａ因子を用いた腫瘍のない多能性胚性幹様細胞の生成
WO2009101407A2 (en) 2008-02-11 2009-08-20 Cambridge Enterprise Limited Improved reprogramming of mammalian cells, and the cells obtained
EP2090649A1 (en) 2008-02-13 2009-08-19 Fondazione Telethon Method for reprogramming differentiated cells
WO2009102983A2 (en) 2008-02-15 2009-08-20 President And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
US9534205B2 (en) 2008-03-17 2017-01-03 The Scripps Research Institute Combined chemical and genetic approaches for generation of induced pluripotent stem cells
WO2009114949A1 (en) 2008-03-20 2009-09-24 UNIVERSITé LAVAL Methods for deprogramming somatic cells and uses thereof
EP2276838A4 (en) 2008-04-07 2012-02-01 Nupotential Inc RE-PROGRAMMING A CELL BY INDUCING A PLURIPOTENTIC GENE THROUGH RNA INTERFERENCE
JP5340265B2 (ja) 2008-06-27 2013-11-13 国立大学法人京都大学 効率的な人工多能性幹細胞の樹立方法
JP4281071B1 (ja) 2008-07-10 2009-06-17 学校法人兵庫医科大学 Ｖγ９Ｖδ２Ｔ細胞の増殖剤、活性化Ｖγ９Ｖδ２Ｔ細胞の製造方法およびこれらの利用
AU2009271149A1 (en) 2008-07-14 2010-01-21 Oklahoma Medical Research Foundation Production of pluripotent cells through inhibition of Bright/ARID3a function
WO2010147612A1 (en) 2009-06-18 2010-12-23 Lixte Biotechnology, Inc. Methods of modulating cell regulation by inhibiting p53
US20120034192A1 (en) 2008-09-19 2012-02-09 Young Richard A Compositions and methods for enhancing cell reprogramming
WO2010033906A2 (en) 2008-09-19 2010-03-25 President And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
WO2010042800A1 (en) 2008-10-10 2010-04-15 Nevada Cancer Institute Methods of reprogramming somatic cells and methods of use for such cells
EP2342333A4 (en) 2008-10-30 2013-05-08 Univ Kyoto Method for producing induced pluripotent stem cells
US20110059526A1 (en) 2008-11-12 2011-03-10 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through use of an hdac modulator
EP2376626A4 (en) 2008-12-13 2012-10-17 Dna Microarray MICRO-ENVIRONMENTAL NICHE ASSAY FOR SCREENING OF INDUCED PLURIPOTENT STEM CELLS (CIPS)
CA2753845C (en) 2009-02-27 2019-10-29 Kyoto University Nuclear reprogramming substance comprising glis1
US20120122212A1 (en) 2009-03-06 2012-05-17 Marica Grskovic Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
WO2010111422A2 (en) 2009-03-25 2010-09-30 The Salk Institute For Biological Studies Induced pluripotent stem cell generation using two factors and p53 inactivation
WO2010111409A2 (en) 2009-03-25 2010-09-30 The Salk Institute For Biological Studies Pluripotent stem cells
US8852940B2 (en) 2009-04-01 2014-10-07 The Regents Of The University Of California Embryonic stem cell specific microRNAs promote induced pluripotency
WO2010124290A2 (en) 2009-04-24 2010-10-28 Whitehead Institute For Biomedical Research Compositions and methods for deriving or culturing pluripotent cells
AU2010254811B2 (en) * 2009-06-05 2015-02-19 FUJIFILM Cellular Dynamics, Inc. Reprogramming T cells and hematopoietic cells
WO2010147395A2 (en) 2009-06-16 2010-12-23 Korea Research Institute Of Bioscience And Biotechnology Medium composition comprising neuropeptide y for the generation, maintenance, prologned undifferentiated growth of pluripotent stem cells and method of culturing pluripotent stem cell using the same
US9206394B2 (en) * 2010-02-03 2015-12-08 The University Of Tokyo Method for reconstructing immune function using pluripotent stem cells
JP6344821B2 (ja) 2011-11-21 2018-06-20 ユニバーシティ・ヘルス・ネットワーク 造血前駆体の集団および造血前駆体のための幹細胞を富化する方法
CA3185368A1 (en) * 2013-04-03 2014-10-09 Memorial Sloan-Kettering Cancer Center Effective generation of tumor-targeted t cells derived from pluripotent stem cells
WO2016010155A1 (ja) * 2014-07-18 2016-01-21 宏 河本 抗原特異的ｔ細胞受容体遺伝子を有する多能性幹細胞の製造方法
SG11201701191WA (en) * 2014-07-18 2017-03-30 Univ Kyoto Method for inducing t cells for cell-based immunotherapy from pluripotent stem cells
US20170333480A1 (en) * 2014-11-05 2017-11-23 Board Of Regents, The University Of Texas System Gene modified immune effector cells and engineered cells for expansion of immune effector cells
EP3219791A4 (en) * 2014-11-13 2018-07-18 Kyoto University Method for induction of t cells from pluripotent stem cells
GB201421716D0 (en) 2014-12-05 2015-01-21 King S College London Cell expansion procedure
KR20180086183A (ko) * 2015-09-03 2018-07-30 더 유에이비 리서치 파운데이션 유전자 조작 약물 내성 t 세포 및 이것의 사용 방법
US11987811B2 (en) * 2015-10-15 2024-05-21 Kyoto University Method for producing CD4-positive T cells from pluripotent stem cells
TW202344686A (zh) 2015-10-30 2023-11-16 美國加利福尼亞大學董事會 從幹細胞產生t細胞之方法及使用該t細胞之免疫療法
HUE056387T2 (hu) * 2016-04-15 2022-02-28 Univ Kyoto Eljárás antigénspecifikus CD8-pozitív T-sejtek indukálására
JP7059481B2 (ja) * 2016-06-23 2022-04-26 国立大学法人京都大学 Ｃｄ４ｃｄ８両陽性ｔ細胞の製造方法
EP3572502B1 (en) 2017-01-20 2023-01-11 Kyoto University Method for producing cd8alpha +beta + cytotoxic t cells
JP7224021B2 (ja) * 2017-02-03 2023-02-17 国立大学法人神戸大学 人工多能性幹細胞の作製方法
SG10202106515SA (en) * 2017-02-07 2021-07-29 Agency Science Tech & Res Methods and kits for generating mimetic innate immune cells from pluripotent stem cells
JP2018133727A (ja) 2017-02-16 2018-08-23 富士通株式会社 無線通信システム、無線通信装置、及びビームパターン決定方法
EP3597734A4 (en) * 2017-03-14 2021-03-03 Kyoto University METHOD FOR PRODUCING HELPER T-CELLS FROM PLURIPOTENT STEM CELLS
JP7109916B2 (ja) 2017-12-27 2022-08-01 株式会社ディスコ 分割装置
SG11202100260QA (en) * 2018-07-13 2021-02-25 Univ Kyoto METHOD FOR PRODUCING γδ T CELLS
WO2020027094A1 (ja) * 2018-07-31 2020-02-06 サイアス株式会社 ｉＰＳ細胞を介して再生Ｔ細胞集団を製造する方法
JP7723935B2 (ja) * 2019-11-01 2025-08-15 国立大学法人京都大学 Ｔ細胞の製造方法
CN114761560A (zh) * 2019-11-25 2022-07-15 国立大学法人京都大学 T细胞主细胞库
WO2022059780A1 (ja) * 2020-09-18 2022-03-24 サイアス株式会社 ｉＰＳ細胞を介する再生Ｔ細胞の製造方法
AU2021349574A1 (en) * 2020-09-24 2023-05-11 Kyoto University Method for producing effector cell having desired specificity
EP4273234A4 (en) * 2021-01-04 2025-04-23 Thyas Co. Ltd. Method for producing a regenerated T cell via an IPS cell

Similar Documents

Publication Publication Date Title
JP2024096899A5 (enExample)
JP2022180510A (ja) 胎児ヘモグロビンの発現を増加させる方法
JP2020511131A5 (enExample)
JP2003527856A5 (enExample)
JP2004537252A5 (enExample)
FR2681786B1 (enExample)
WO2004101756A3 (en) Ovr110 antibody compositions and methods of use
Zhang et al. Ligand-gated ion channel P2X7 regulates hypoxia-induced factor-1α mediated pain induced by dental pulpitis in the medullary dorsal horn
JPWO2020150478A5 (enExample)
WO2020221291A1 (zh) 一种血红蛋白病治疗有效性预测方法
Stévenin et al. Relationship between nuclear giant-size dRNA and microsomal dRNA of rat brain
JPWO2022051749A5 (enExample)
MX2024013891A (es) Vacunas y métodos para usarlas para tratar cáncer relacionado con wnt
JP2020535832A5 (enExample)
JPWO2020002540A5 (enExample)
WO2024178397A3 (en) Modified immune effector cells and methods of use
JPWO2022216837A5 (enExample)
JPWO2020198587A5 (enExample)
JP2006505280A5 (enExample)
JPWO2021209759A5 (enExample)
WO2004104173A3 (en) Ovr115 ANTIBODY COMPOSITION AND METHODS OF USE
JPWO2022094348A5 (enExample)
JP2019508056A5 (enExample)
JPH09511400A (ja) 交互スプライシングによって生成されるヒトインターロイキン変異体
CN118345080B (zh) 一种抗耗竭t细胞及其制备方法、应用